Response to "Pervasive Sequence Patents Cover the Entire Human Genome"All Faculty Scholarship
AbstractIn a widely reported article by Jeffrey Rosenfeld and Christopher Mason published in Genome Medicine, significant misstatements were made, because the authors did not sufficiently review the claims – which define the legal scope of a patent – in the patents they analyzed. Specifically, the authors do not provide an adequate basis for their assertion that 41% of the genes in the human genome have been claimed.
Citation InformationResponse to "Pervasive Sequence Patents Cover the Entire Human Genome," 6 Genome Med. 14 (2014) (co-authored)